Biophysical Journal 71: 1672-1679 (1996)
© 1996 the Biophysical Society

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Choo, L P Articles by Mantsch, H H Search for Related Content PubMed PubMed Citation Articles by Choo, L P Articles by Mantsch, H H

In situ characterization of beta-amyloid in Alzheimer's diseased tissue by synchrotron Fourier transform infrared microspectroscopy.

Institute for Biodiagnostics, National Research Council Canada, Winnipeg, Manitoba.

ABSTRACT

We report the first evidence of the structure of beta-amyloid protein as it exists in situ within a slice of human Alzheimer's diseased brain tissue. Using a Fourier transform infrared microspectroscopic technique, areas of interest can be selected for spectral measurements with regions of potential contamination masked. In so doing, it is possible to obtain infrared spectra only of beta-amyloid and not the surrounding grey matter within which it lies. However, to obtain spectra of high-quality signal-to-noise ratio using a conventional infrared source, we were limited to aperture sizes between 24 microns x 24 microns to 50 microns x 50 microns. Markedly improved high-quality spectra were acquired with infrared radiation provided by a synchrotron light source (National Synchrotron Light Source, Brookhaven National Laboratories), using aperture sizes as small as 12 microns x 12 microns. This allowed spectroscopic mapping of brain tissue regions containing amyloid. We observe that in situ protein of grey matter exist predominantly in an alpha-helical and/or unordered conformation, whereas within amyloid deposits a beta-sheet structure predominates. The hydrogen bonding strength of the beta-structure found in situ is different from that reported in the literature for isolated/chemically synthesized beta-amyloid peptides.

This article has been cited by other articles:

				T. R. Jahn, G. A. Tennent, and S. E. Radford A Common {beta}-Sheet Architecture Underlies in Vitro and in Vivo {beta}2-Microglobulin Amyloid Fibrils J. Biol. Chem., June 20, 2008; 283(25): 17279 - 17286. [Abstract] [Full Text] [PDF]

				S. Zirah, S. A. Kozin, A. K. Mazur, A. Blond, M. Cheminant, I. Segalas-Milazzo, P. Debey, and S. Rebuffat Structural Changes of Region 1-16 of the Alzheimer Disease Amyloid beta-Peptide upon Zinc Binding and in Vitro Aging J. Biol. Chem., January 27, 2006; 281(4): 2151 - 2161. [Abstract] [Full Text] [PDF]

				M. Gallant, M. Rak, A. Szeghalmi, M. R. Del Bigio, D. Westaway, J. Yang, R. Julian, and K. M. Gough Focally Elevated Creatine Detected in Amyloid Precursor Protein (APP) Transgenic Mice and Alzheimer Disease Brain Tissue J. Biol. Chem., January 6, 2006; 281(1): 5 - 8. [Abstract] [Full Text] [PDF]

				G. Zandomeneghi, M. R.H. Krebs, M. G. McCammon, and M. Fandrich FTIR reveals structural differences between native {beta}-sheet proteins and amyloid fibrils Protein Sci., December 1, 2004; 13(12): 3314 - 3321. [Abstract] [Full Text] [PDF]

				I. Qahwash, K. L. Weiland, Y. Lu, R. W. Sarver, R. F. Kletzien, and R. Yan Identification of a Mutant Amyloid Peptide That Predominantly Forms Neurotoxic Protofibrillar Aggregates J. Biol. Chem., June 13, 2003; 278(25): 23187 - 23195. [Abstract] [Full Text] [PDF]

				T. L. S. Benzinger, D. M. Gregory, T. S. Burkoth, H. Miller-Auer, D. G. Lynn, R. E. Botto, and S. C. Meredith Propagating structure of Alzheimer's beta -amyloid(10-35) is parallel beta -sheet with residues in exact register PNAS, November 10, 1998; 95(23): 13407 - 13412. [Abstract] [Full Text] [PDF]